A new approach to restore lung function and reduce antibiotic resistance Read More

Disrupting bacterial biofilms and mucus to alter the progression of pulmonary diseases

View our Pipeline

Developing a new class of
glycopolymer-based therapeutics
that target key drivers
of pulmonary decline Read More


August 09, 2018

Synspira’s PAAG Therapy Demonstrates Persistence Against Pseudomonas aeruginosa Persister Cells

 Results published in Frontiers in Microbiology-Antimicrobials, Resistance and Chemotherapy 

Read More

A breath of fresh air in the treatment of lung disease.